Support reforms to step therapy, prior authorization, pharmacy benefit manager spread pricing in Medicaid, Medicare Advantage plan switching, and pharmacy drug acquisition cost reporting.

Mark R. Warner · Virginia · Democratic

policy impact 0.82 specificity 0.90 extraction confidence 90%

Commitment kind: action. Promised action: Support legislation reforming step therapy and prior authorization, banning PBM spread pricing in Medicaid, allowing certain Medicare Advantage mid-year plan switches, and requiring pharmacy acquisition-cost survey responses.. Promised outcome: Health insurers and pharmacy benefit managers face new patient-protection and transparency rules.. Deadline: unknown; not assumed expired. Official Senate press release announcing Warner's 2026 Health CARE Act while serving as U.S. Senator from Virginia.

Contest this claim

Occurrences

Ensure health insurance companies and pharmacy benefit managers do not put profit over patients by reforming the use of step therapy and prior authorization, banning PBM spread pricing in Medicaid, allowing Medicare Advantage enrollees to switch plans mid-year if their provider leaves their network, and requiring all retail, mail-order, and specialty pharmacies to respond to surveys that collect drug acquisition costs.

Warner's Health CARE Act would change insurer and PBM practices through step therapy, prior authorization, Medicaid spread-pricing, Medicare Advantage switching, and pharmacy reporting reforms.

Warner Introduces New Sweeping Health Care Bill to Lower Costs, Expand Coverage, and Improve Access to Care
primary · press_release · model gpt-5.5

Evidence

verified · Source version 87881 · locator 1281

Mr. Crapo (for himself, Mr. Wyden, Mr. Grassley, Mr. Bennet, Mr. Cornyn, Mr. Warner, Mr. Thune, Mr. Whitehouse, Mr. Cassidy, Ms. Hassan, Mr. Lankford, Ms. Cortez Masto, Mr. Daines, Ms. Smith, Mr. Barrasso, Mr. Luján, Mr. Tillis, Mr. Warnock, Mrs. Blackburn, Mr. Welch, and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Finance

Fetched verbatim passage. AI summary (separate from source): Warner was an original cosponsor of a 119th Congress PBM bill covering Medicaid accurate pharmacy payments, Medicaid spread-pricing prevention, Medicare pharmacy access/choice, and PBM accountability. The action was referral to committee, so it documents support/effort but not enactment.

partial same_term A for effort

S. 3345 (IS) - PBM Price Transparency and Accountability Act - BILLS-119s3345is | Content Details | GovInfo
secondary · model gpt-5.5 · confidence 86%

Contest this evidence item

unverified · Source version 87883 · locator unknown

U.S. Sens. Mark R. Warner (D-VA), a member of the Finance Committee, and Bill Cassidy, M.D. (R-LA), Chair of the Health, Education, Labor, and Pensions (HELP) Committee, reintroduced the Ensuring Accurate Payments to Specialty Pharmacies Act

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The latest concrete official evidence found near the lookback window is Warner reintroducing a bill to expand federal drug acquisition cost surveys for specialty and mail-order pharmacies. This supports the acquisition-cost-reporting portion, but it is still a legislative attempt rather than enacted reform.

partial same_term A for effort

Warner, Cassidy Introduce Bipartisan Bill to Improve PBM Reimbursement Data, Protect Patients From Out-of-Pocket Costs
secondary · model gpt-5.5 · confidence 83%

Contest this evidence item

Assessments

Public state: pending As of 2026-10-10 · verified · . Original AI recommendation (not independently established): unresolved. unknown A for effort

The verified commitment promises substantive health-insurance and PBM reforms, not merely bill introduction. The verified passage shows Warner was listed among senators introducing a related bill that was read twice and referred to the Finance Committee, which supports material legislative effort in the same Senate context. However, the verified evidence does not show enactment or any attributable partial implemented outcome by the as_of_date, and no deadline has expired. Under the rules, an attempt without enactment is unresolved.

provider codex_cli · model gpt-5.5 · confidence 90%